The Brain, Neurological Features and Neuropsychological Functioning in Adults With Sapropterin Dihydrochloride Treated Phenylketonuria
Phase of Trial: Phase IV
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Sapropterin (Primary)
- Indications Phenylketonuria
- Focus Therapeutic Use
- 01 Feb 2018 Status changed from active, no longer recruiting to completed.
- 04 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 29 Nov 2016 Planned End Date changed from 1 Jan 2017 to 1 Sep 2017.